Search Results 951-960 of 16331 for Chronic Lymphocytic Leukemia

  1. A Study to Evaluate CC-96191 to Treat Participants With Relapsed or Refractory Acute Myeloid Leukemia - Mayo Clinic

    Phase 4 trials look at long-term safety and ... leukemia (R/R AML). The dose escalation (Part A) ... Participant has persistent, clinically ...

  2. A Study to Compare the Effectiveness, Safety and Tolerability of P1101 vs. Anagrelide for Essential Thrombocythemia - Mayo Clinic

    The primary purpose of this study is to assess long-term ... History of any malignancy within 5 years (except Stage 0 chronic lymphocytic leukemia, basal cell, ...

  3. Publications - Allison C. Rosenthal, D.O. - Mayo Clinic

    A case of B-cell lymphoblastic leukemia cutis flaring following CAR T-cell therapy in a patient with refractory acute lymphoblastic leukemia. JAAD Case Rep ...

  4. Sharing Mayo Clinic: Helping others after a stem cell transplant

    ... leukemia. Family members were often with her at ... A life-changing diagnosis. Kim's journey with ... Kim suffered from persistent, severe headaches.

  5. Chronic granulomatous disease - Care at Mayo Clinic

    Your Mayo Clinic care team. Doctors trained in allergic diseases, clinical genomics and pulmonary medicine work with other specialists to diagnose and treat ...

  6. A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib to To Treat Newly-diagnosed AML with or without FLT3 Mutations - Mayo Clinic

    ... leukemia with or without FLT3 mutations. ... diagnosis of AML (e.g., Down syndrome, fragile X ... - Patients with persistent cardiac dysfunction prior to enrollment ...

  7. Cancer Clinical Trials - Mayo Clinic Research

    Although it is potentially lifesaving for a variety of primarily malignant diseases, allogeneic HCT carries a significant burden of short- and long-term ...

  8. Multi-phase Dual Energy for Quantitative and Radiologic Evaluation of Chronic Liver Disease - Mayo Clinic

    The purpose of this study is to assess the combined impact of post-processing methods that quantify potential biomarkers of chronic liver disease (AEF, fECS) ...

  9. A Study to Evaluate Pevonedistat and Venetoclax Plus Azacitidine in Adults with Acute Myeloid Leukemia Who Are Unfit for Intensive Chemotherapy - Mayo Clinic

    Genetic diagnosis of acute promyelocytic leukemia. Eligible for intensive chemotherapy and/or allogeneic stem cell transplantation. Extramedullary AML ...

  10. Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia - Mayo Clinic

    ... leukemia. Drugs used in chemotherapy, such as cytarabine, daunorubicin ... chronic myelogenous leukemia (CML) are not eligible; patients with known ...